0% found this document useful (0 votes)
4 views

2014 IPO Project Valuation Model

The document provides a detailed financial analysis and valuation of SULLY, including income statement, balance sheet, tax information, and discount rate inputs. It presents a discounted cash flow (DCF) valuation resulting in a total firm value of approximately $5.31 billion and an equity value per share of $25.15. Additionally, it includes multiples valuation and industry comparisons for further context.

Uploaded by

hi0742
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as XLS, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
4 views

2014 IPO Project Valuation Model

The document provides a detailed financial analysis and valuation of SULLY, including income statement, balance sheet, tax information, and discount rate inputs. It presents a discounted cash flow (DCF) valuation resulting in a total firm value of approximately $5.31 billion and an equity value per share of $25.15. Additionally, it includes multiples valuation and industry comparisons for further context.

Uploaded by

hi0742
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as XLS, PDF, TXT or read online on Scribd
You are on page 1/ 7

IPO Project Valuation Models

Student Name(s):
SULLY'S Current Financial Information
Please input values into the Yellow Boxes, DO NOT round to 000s
(note values on SULLY'S financials are in 000s)
I. Income Statement
Current EBIT = $ 179,003,000
Current Interest Expense = $ 13,887,000
Current Capital Spending $ 32,948,000
Current Depreciation and Amortization = $ 4,860,000
Current Revenues = $ 917,760,000

II. Balance Sheet This period Last period


Current Non-cash Working Capital = $ 112,151,000 $ 73,830,000
Book Value of Debt = $ 391,057,000 $ 395,017,000
Book Value of Equity = $ (87,297,000) $ (191,085,000)
Cash & Marketable Securities = $ 95,788,000

III. Tax Information


Marginal tax rate = 35.00%

IV. Discount Rate Inputs


Current Cost of Borrowing = 3.55%
Current Market Value of Debt = $ 391,057,000

V. Stable Growth Inputs


Expected Revenue Growth Rate in Perpetutity = 2.16% Speed of convergence
Expected Operating Margin = 21.40% 2
Expected Debt to Capital(MV) Ratio for the Firm = 21.10%
Expected Beta = 0.93
Expected Cost of Debt = 4.78%
Return on Equity = 27.03%
Return on Capital for the Firm = 21.98%

VI. Per Share Inputs


Number of Shares Outstanding = 195,745,670

VII. General Information


Current long term government bond rate = 2.19%
Estimated Market Risk Premium = 5.00%

VIII. Expected Revenue Growth


Year Expected Growth Rate
1 7.14%
2 6.97%
3 6.80%
4 6.63%
5 6.46%
6 6.29%
7 6.12%
8 5.95%
9 5.78%
10 5.42%
Compounded Average 6.35%
DCF VALUATION
Base 1 2 3 4 5 6 7 8 9 10 Terminal Year
Revenue Growth Rate 7.14% 6.97% 6.80% 6.63% 6.46% 6.29% 6.12% 5.95% 5.78% 5.42% 2%
Revenues $917,760,000 $983,288,064 $1,051,823,242 $1,123,347,223 $1,197,825,143 $1,275,204,648 $1,355,415,020 $1,438,366,419 $1,523,949,221 $1,612,033,486 $1,699,405,701 $1,736,112,864
Operating Margin 19.50% 20.14% 20.56% 20.84% 21.03% 21.15% 21.23% 21.29% 21.33% 21.35% 21.37% 21.40%
EBIT $179,003,000 $197,997,091 $216,228,384 $234,086,711 $251,849,300 $269,710,442 $287,803,090 $306,214,564 $324,997,932 $344,180,263 $363,114,162 $371,528,153
Taxes $62,651,050 $69,298,982 $75,679,934 $81,930,349 $88,147,255 $94,398,655 $100,731,082 $107,175,097 $113,749,276 $120,463,092 $127,089,957 $130,034,854
EBIT(1-t) $116,351,950 $128,698,109 $140,548,449 $152,156,362 $163,702,045 $175,311,787 $187,072,009 $199,039,467 $211,248,656 $223,717,171 $236,024,206 $241,493,299
+ Depreciation $4,860,000 $5,182,218 $5,516,989 $5,864,008 $6,222,885 $6,593,147 $6,974,231 $7,352,234 $7,511,042 $7,673,281 $7,839,024 $8,008,347
- Capital Expenditure $32,948,000 $35,300,487 $37,760,931 $40,328,674 $43,002,466 $45,780,425 $48,660,014 $51,638,006 $54,710,468 $57,872,733 $61,009,435 $27,252,102
- Chg WC $38,321,000 $8,007,581 $8,375,053 $8,740,287 $9,101,261 $9,455,837 $9,801,771 $10,136,727 $10,458,286 $10,763,967 $10,676,954 $4,485,644
FCFF $49,942,950 $90,572,259 $99,929,454 $108,951,408 $117,821,204 $126,668,672 $135,584,455 $144,616,968 $153,590,944 $162,753,752 $172,176,840 $217,763,900
NOL $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Terminal Value $5,594,682,569

Cost of Capital Calculations


Tax Rate 35.00% 35.00% 35.00% 35.00% 35.00% 35.00% 35.00% 35.00% 35.00% 35.00% 35.00% 35.00%
Debt Ratio 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 84.22% 80.27% 73.70% 60.55% 21.10% 21.10%
Beta 0.73 0.73 0.73 0.73 0.73 0.73 0.77 0.81 0.85 0.89 0.93 0.93
Cost of Equity 5.84% 5.84% 5.84% 5.84% 5.84% 5.84% 6.04% 6.24% 6.44% 6.64% 6.84% 6.84%
Cost of Debt 3.55% 3.55% 3.55% 3.55% 3.55% 3.55% 3.80% 3.86% 3.96% 4.17% 4.78% 4.78%
After-tax cost of debt 2.31% 2.31% 2.31% 2.31% 2.31% 2.31% 2.47% 2.51% 2.57% 2.71% 3.11% 3.11%
Cost of Capital 2.31% 2.31% 2.31% 2.31% 2.31% 2.31% 3.03% 3.24% 3.59% 4.26% 6.05% 6.05%

Computed Variables (These are measures of how efficiently your firm is investing over time)
Total Capital Invested $303,760,000.00 $ 341,885,851 $ 382,504,846 $ 425,709,799 $ 471,590,641 $ 520,233,756 $ 571,721,310 $ 626,143,809 $ 683,801,520 $ 744,764,940 $ 808,612,305 $ 832,341,705
Reinvestment Rate 57.08% 29.62% 28.90% 28.40% 28.03% 27.75% 24.16% 23.27% 21.77% 18.79% 9.83% 9.83%
Increase in Revenue/Increase in Capital 1.72 1.69 1.66 1.62 1.59 1.56 1.52 1.48 1.44 1.37 1.55
Return on Capital 42.37% 41.11% 39.78% 38.45% 37.17% 35.96% 34.81% 33.74% 32.72% 31.69% 21.98%

Present Value Calculations


Cumulative WACC 1.02308244 1.04669768040159 1.07085801750597 1.09557603415807 1.12086460296295 1.1548453799112 1.1923095255127 1.235126834087 1.287730208375 1.36566798023665
Present Value of FCFF $ 88,528,798 $ 95,471,172 $ 101,742,161 $ 107,542,699 $ 113,009,789 $ 117,404,855 $ 121,291,464 $ 124,352,366 $ 126,388,083 $ 126,075,183
Present Value of Terminal Value $ 4,096,663,794

The Valuation
PV of FCFF during high growth phase = $ 1,121,806,569
PV of Terminal Value = $ 4,096,663,794
Value of Operating Assets of the firm = $ 5,218,470,363
Value of Cash & Non-operating assets= $ 95,788,000
Value of Firm = $ 5,314,258,363
- Value of Outstanding Debt = $ 391,057,000
Value of Equity = $ 4,923,201,363
Value of Equity in Common Stock = $ 4,923,201,363
Value of Equity per share = $ 25.15
MULTIPLES VALUATION

Equity Multiples

P / E Ratio 54.30
SULLY'S Price per Share $ 28.42

PEG 1.00
Estimated EPS Growth Rate 8.00%
SULLY'S Price per Share $ 4.19

P/Sales 5.03
SULLY'S Price per Share $ 23.58

Enterprise Multiples

EV/EBITDA 26.20
SULLY'S Price per Share $ 24.61

EV/Sales 5.40
SULLY'S Price per Share $ 25.32
Industry Name Number of firmsUnlevered Beta Debt / Equity Debt / Value Equity / Value ROE ROC Effective Tax Rate
After-tax Operating Margin
Net Margin Sales/Capital EV/Sales
Advertising 31 1.75 43.26% 30.20% 69.80% 8.89% 10.54% 10.73% 7.44% 3.63% 1.42 1.14
Beverage 34 0.77 26.52% 20.96% 79.04% 24.58% 12.95% 19.14% 15.60% 13.99% 0.83 3.03
Chemical 31 1.39 22.37% 18.28% 81.72% 19.26% 13.81% 21.73% 9.30% 8.79% 1.48 1.62
Diversified Co. 107 0.71 102.24% 50.55% 49.45% 33.28% 8.01% 15.55% 11.76% 9.21% 0.68 2.11
Drug 279 1.08 15.46% 13.39% 86.61% 22.64% 15.02% 5.36% 16.96% 17.99% 0.89 2.85
Food Products 112 0.73 29.53% 22.80% 77.20% 13.39% 11.88% 20.00% 14.62% 7.93% 1.82 1.08
Healthcare Information 25 1.20 6.35% 5.97% 94.03% 11.00% 9.45% 22.19% 7.64% 8.81% 1.24 3.82
Household Products 26 0.95 18.99% 15.96% 84.04% 21.80% 14.52% 25.12% 12.79% 11.66% 1.13 2.21
Insurance 30 1.54 64.14% 39.08% 60.92% 10.45% NA 28.04% NA NA NA NA
Packaging & Container 26 0.88 51.82% 34.13% 65.87% 17.52% 10.40% 24.23% 7.02% 13.46% 1.48 1.06
Paper/Forest Products 32 0.96 59.86% 37.45% 62.55% 8.40% 11.01% 10.61% 9.84% 4.63% 1.12 1.06
Pharmacy Services 19 1.00 20.48% 17.00% 83.00% 14.82% 11.18% 24.67% 3.14% 2.91% 3.56 0.53
Retail Store 37 1.14 25.58% 20.37% 79.63% 21.01% 13.60% 25.02% 3.83% 3.45% 3.55 0.59
Retail/Wholesale Food 30 0.64 41.34% 29.25% 70.75% 16.43% 10.38% 31.21% 2.07% 4.16% 5.02 0.35
Toiletries/Cosmetics 15 1.20 20.64% 17.11% 82.89% 62.53% 19.54% 20.30% 7.24% 7.37% 2.70 1.48
Average 5891 0.92 46.64% 31.81% 68.19% 16.07% 12.21% 15.48% 12.62% 8.32% 0.97 1.67
Company Name Brief Business Description Stock Price
PetMed Express Online pet pharmacy offering prescription and non-prescription pet medications and other health products for dogs, cats and horses $ 16.83
IDEXX Labs The global market leader in diagnostics and information technology solutions for animal health and water and milk quality $ 77.03
Zoetis World's largest producer of medicine and vaccinations for pets and livestock $ 46.96
Freshpet Manufacturer of refrigerated food and treats for dogs and cats using natural ingredients, and are the first in the fresh and refrigerated category to be distributed across North America $ 13.18
Trupanion Trupanion is a pet insurance provider that offers and administers cat and dog insurance in the United States, Canada and Puerto Rico $ 7.24
Hormel Foods A food company that produces Spam luncheon meat $ 63.59
ConAgra Foods $ 43.95
Mondelez International $ 44.00
Pinnacle Foods Packaged foods company that specializes in the shelf stable and frozen $ 46.77
Nestlé Swiss multinational food and beverage company, Subsidiary Nestlé Purina Petcare produces and markets pet food, treats and litter $ 76.20
Colgate-Palmolive American multinational consumer products company, including subsidairy Hills Pets which produces high quality pet foods $ 66.29
WhiteWave Foods Consumer packaged food and beverage company that sells branded plant-based foods and beverages, coffee creamers and beverages, premium dairy products, and organic produce $ 46.44
United Natural Foods Leading national distributor of natural and organic foods, specialty foods, and related products $ 49.12
(blank)
(blank)
(blank)
Computed
Average $ 45.97
Shares EPS Growth P/E PEG
Outstanding Market Cap Enterprise Sales Revenue EBITDA 5-Year 5-Year 5-Year
Beta EPS
(Mils.) ($ Bils.) Value ($ Bils.) Growth ($ Bils.) Estimate Estimate Estimate P / Sales EV / EBITDA EV / Sales
20.33 $ 0.34 $ 0.283 0.38 $ 0.228 (0.76%) $ 0.031 $ 0.92 5.00% 18.29 3.66 1.50 9.05 1.24
92.00 $ 7.09 $ 7.950 0.85 $ 1.560 7.93% $ 0.332 $ 2.11 14.33% 36.51 2.55 4.54 23.96 5.10
498.94 $ 23.43 $ 27.010 0.92 $ 4.810 5.79% $ 1.390 $ 1.67 12.68% 28.12 2.22 4.87 19.43 5.62
33.50 $ 0.44 $ 0.422 1.16 $ 0.102 14.80% $ 0.156 $ (0.10) 25.00% (131.80) (5.27) 4.31 2.70 4.12
28.27 $ 0.20 $ 0.172 1.24 $ 0.131 15.86% $ (0.017) $ (0.65) 24.09% (11.14) (0.46) 1.56 (10.31) 1.31
264.28 $ 16.81 $ 15.800 1.37 $ 9.500 7.35% $ 1.150 $ 2.54 12.01% 25.04 2.08 1.77 13.74 1.66
431.75 $ 18.98 $ 26.820 0.38 $ 15.830 5.56% $ 2.110 $ 2.24 8.04% 19.62 2.44 1.20 12.71 1.69
1610.00 $ 70.84 $ 90.200 1.46 $ 32.590 (3.25%) $ 5.070 $ 1.27 (8.81%) 34.65 (3.93) 2.17 17.79 2.77
116.59 $ 5.45 $ 7.750 0.27 $ 2.630 9.54% $ 0.459 $ 2.21 23.33% 21.16 0.91 2.07 16.90 2.95
3132.00 $ 238.66 $ 261.660 - $ 89.870 (0.97%) $ 17.860 $ 3.43 5.35% 22.22 4.15 2.66 14.65 2.91
900.13 $ 59.67 $ 65.640 0.98 $ 16.740 2.42% $ 4.550 $ 2.84 7.58% 23.34 3.08 3.56 14.43 3.92
175.76 $ 8.16 $ 9.730 1.72 $ 3.600 10.69% $ 0.415 $ 1.16 20.31% 40.03 1.97 2.27 23.42 2.70
50.09 $ 2.46 $ 2.840 1.42 $ 7.890 14.48% $ 0.290 $ 2.86 12.31% 17.17 1.40 0.31 9.80 0.36

12.09% 25.15 2.45 2.48 15.81 2.82


565.66 $ 34.81 $ 39.714 1.01 $ 14.268 6.88% $ 2.600 $ 1.73 12.38% 11.02 1.14 2.52 12.94 2.80

You might also like